Skip to main content
logo
GlobeStar Therapeutics Corporation (GSTC)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 29, 2026, 4:00 PM EST

GlobeStar Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jul '26 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
Market Capitalization
0231631
Market Cap Growth
0%-32.91%-83.63%450.33%194.93%-35.11%
Enterprise Value
-231634
Last Close Price
0.000.000.000.030.010.01

Price Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jul '26 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
PS Ratio
----38523.182366.49
PB Ratio
0.00-1.25-2.24-22.49-4.50-1.47

EV Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jul '26 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
EV/Sales Ratio
----39364.349563.45

Financial Efficiency

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jul '26 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
Debt / Equity Ratio
-0.20-0.25-0.13-0.15-0.23-0.17
Net Debt / Equity Ratio
-0.20-0.25-0.13-0.14-0.11-0.02
Net Debt / EBITDA Ratio
---0.12-0.01-0.24-0.04
Net Debt / FCF Ratio
-2.22-1.78-0.47-0.13-0.30-0.05
Asset Turnover
----0.000.00
Inventory Turnover
----1.770.01
Quick Ratio
0-0.010.010.110.12
Current Ratio
0.05-0.010.010.120.17
Return on Assets (ROA)
---9961.77%-11857.25%-163.55%-147.92%
Return on Capital Employed (ROCE)
49.50%130.00%105.90%1253.00%46.10%46.10%

Yields

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jul '26 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
Earnings Yield
-74077.12%-108.71%-55.67%-60.04%-18.26%-67.12%
FCF Yield
-11948.67%-11.48%-12.23%-4.60%-8.14%-25.86%
Buyback Yield / Dilution
-39.10%-31.63%-30.38%-61.73%-184.50%-85.40%